Sai Life Sciences Sustainability Report 2022

33 ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................... High Content Screening (HCS) Assays at the forefront A Powerful Approach to Systems Cell Biology and Phenotypic Drug Discovery HCS provides data specifically at the target site, as well as any off-target effects, all in the same assay. We have developed wide range of assays starting from simple downstream marker modulations like nuclear translocation, cytosol to plasma membrane translocation, post translational modifications to complex autophagy, mitochondrial morphology/fragmentation, RNA/protein aggregate formation, cell shape/morphology, target distribution changes and neurite outgrowth assays over a period of 3 years in 384 well format. .

RkJQdWJsaXNoZXIy MTIwMDc4NQ==